Abstract
Despite radical chemo-radiotherapy (CRT), many patients with intermediate and high risk SCC oropharynx (OPSCC) relapse. Treatment related toxicity limits further uniform intensification across the patient group. If a predictive biomarker for outcomes from CRT can be identified during treatment, individualised and adaptive treatment strategies may be employed for the non-responders. This is the 1st study to use DW MRI for early response assessment in a specific H&N sub-site with sub-type of similar biological behaviour.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have